| Financial Year |
March 31 2023 |
| Monetary Funds |
164,397,235.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
429,731,656.66 |
| Accounts Receivable |
1,635,380,700.14 |
| Advances to Suppliers |
57,412,562.53 |
| Other Receivables |
47,765,366.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
696,023,296.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,805,514.68 |
| Total Current Assets |
3,140,516,164.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
50,001,193.27 |
| Fixed Assetes |
1,509,541,420.75 |
| Under-construction Projects |
107,788,264.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
398,889,632.53 |
| R&D expenses |
3,503,138.02 |
| Goodwill |
1,328,672,062.78 |
| Long-Term Deferred and Prepaid Expenses |
6,210,077.09 |
| Deferred Income Tax Assets |
20,001,947.62 |
| Other Non-Current Assets |
19,633,423.51 |
| Sub-Total of Non-Current Assets |
3,447,040,964.60 |
| Total Assets |
6,587,557,128.93 |
| Short-Term Loans |
1,331,811,929.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
142,226,529.60 |
| Accounts Payable |
672,843,614.04 |
| Accounts Received In Advance |
10,966,565.26 |
| Employee Compensation Payable |
20,380,399.71 |
| Taxes Payable |
21,497,204.90 |
| Interest Payable |
-- |
| Dividend Payable |
400,000.00 |
| Other payables |
157,937,197.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
134,506,447.93 |
| Other Current Liabilities |
428,377,671.90 |
| Sub-Total of Current Liabilities |
3,012,416,582.15 |
| Long-term Loans |
487,167,673.82 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
72,179,935.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
41,795,161.77 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
649,271,467.86 |
| Total Liabilities |
3,661,688,050.01 |
| Paid-In Capital(Or Share Stock) |
1,007,559,123.00 |
| Capital Surplus |
3,386,554,112.99 |
| Surplus Reserve |
11,990,798.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,700,646,094.33 |
| Minority Stockholder's Interest |
209,136,250.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,716,732,828.07 |
| Owner's Equity（Stockholder's Equity） |
2,925,869,078.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,587,557,128.93 |
